These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 17481792)

  • 21. Treatment of clozapine-associated tardive dyskinesia.
    Lin CC; Bai YM; Chen JY; Wang YC; Liou YJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):599-600. PubMed ID: 17920744
    [No Abstract]   [Full Text] [Related]  

  • 22. Improvement of tardive dyskinesia following zopiclone treatment.
    Sugawara N; Yasui-Furukori N; Kaneko S
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):727-8. PubMed ID: 19268505
    [No Abstract]   [Full Text] [Related]  

  • 23. Benzodiazepines and the treatment of anxiety disorders in patients with comorbid alcohol and/or drug abuse.
    Sher L
    Aust N Z J Psychiatry; 2008 Feb; 42(2):170-1. PubMed ID: 18354817
    [No Abstract]   [Full Text] [Related]  

  • 24. Lithium prophylaxis in Kleine-Levin syndrome.
    Loganathan S; Manjunath S; Jhirwal OP; Varghese M; Srinath S
    J Neuropsychiatry Clin Neurosci; 2009; 21(1):107-8. PubMed ID: 19359469
    [No Abstract]   [Full Text] [Related]  

  • 25. No association between lithium full responders and the DRD1, DRD2, DRD3, DAT1, 5-HTTLPR and HTR2A genes in a Sardinian sample.
    Manchia M; Congiu D; Squassina A; Lampus S; Ardau R; Chillotti C; Severino G; Del Zompo M
    Psychiatry Res; 2009 Sep; 169(2):164-6. PubMed ID: 19647327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Benzodiazepines as hypnotics. The importance of short half-life].
    Christensen HR; Simonsen K
    Ugeskr Laeger; 1986 Jul; 148(28):1772-4. PubMed ID: 3529549
    [No Abstract]   [Full Text] [Related]  

  • 27. Magnitude of effect of lithium in short-term efficacy studies of moderate to severe manic episode.
    Storosum JG; Wohlfarth T; Schene A; Elferink A; van Zwieten BJ; van den Brink W
    Bipolar Disord; 2007 Dec; 9(8):793-8. PubMed ID: 18076528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania.
    Yatham LN; Vieta E; Young AH; Möller HJ; Paulsson B; Vågerö M
    Int Clin Psychopharmacol; 2007 Jul; 22(4):212-20. PubMed ID: 17519644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study.
    Severus WE; Kleindienst N; Evoniuk G; Bowden C; Möller HJ; Bohus M; Frangou S; Greil W; Calabrese JR
    J Affect Disord; 2009 Jun; 115(3):466-70. PubMed ID: 19019453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maintenance treatment in bipolar disorder: a reassessment of lithium as the first choice.
    Coryell W
    Bipolar Disord; 2009 Jun; 11 Suppl 2():77-83. PubMed ID: 19538687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tardive dyskinesia and glucid metabolism.
    Brousse G; Meary A; Mouret J; Blanc O; Hueber T; Lemoine P; Llorca PM; Lachaux B
    Hum Psychopharmacol; 2007 Aug; 22(6):373-80. PubMed ID: 17579925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term outcome of patients with bipolar disorder commenced on lithium prophylaxis during hospitalization: a complete 15-year register-based follow-up.
    Licht RW; Vestergaard P; Brodersen A
    Bipolar Disord; 2008 Feb; 10(1):79-86. PubMed ID: 18199244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment-refractory bipolar disorder: classification to aid in clinical management.
    Gajwani P
    Expert Opin Pharmacother; 2009 Aug; 10(12):1907-15. PubMed ID: 19606936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ziprasidone-induced tardive laryngeal dystonia: a case report.
    Tsai CS; Lee Y; Chang YY; Lin PY
    Gen Hosp Psychiatry; 2008; 30(3):277-9. PubMed ID: 18433661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bouncing back: is the bipolar rebound phenomenon peculiar to lithium? A retrospective naturalistic study.
    Franks M; Macritchie KA; Mahmood T; Young AH
    J Psychopharmacol; 2008 Jun; 22(4):452-6. PubMed ID: 18635725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Central pontine and extra-pontine myelinolysis: a complication of lithium toxicity in a pregnant woman.
    Bejot Y; Depierre P; Osseby GV; Troisgros O; Moreau T; Giroud M
    Clin Neurol Neurosurg; 2008 Sep; 110(8):852-4. PubMed ID: 18599196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Possible anti-oxidant and neuroprotective mechanisms of zolpidem in attenuating typical anti-psychotic-induced orofacial dyskinesia: a biochemical and neurochemical study.
    Bishnoi M; Chopra K; Kulkarni SK
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1130-8. PubMed ID: 17513028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tardive dystonia associated with low-dose of amisulpride: a case report.
    Sevincok L; Balci V; Akyildiz U
    J Clin Psychopharmacol; 2008 Oct; 28(5):573-4. PubMed ID: 18794659
    [No Abstract]   [Full Text] [Related]  

  • 39. Aggression, suicide, and lithium treatment.
    Terao T
    Am J Psychiatry; 2008 Oct; 165(10):1356-7; author reply 1357. PubMed ID: 18829890
    [No Abstract]   [Full Text] [Related]  

  • 40. Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: an open-label study.
    Miyaoka T; Furuya M; Yasuda H; Hayashida M; Nishida A; Inagaki T; Horiguchi J
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):761-4. PubMed ID: 18201810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.